Contact
Please use this form to send email to PR contact of this press release:
Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib at ASH 2022
TO:
Please use this form to send email to PR contact of this press release:
Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib at ASH 2022
TO: